Circulating cells: The biofactory for markers of atherosclerotic disease

European Heart Journal

Volumn 29, Issue 22, 2008, Pages 2701-2702

  Pasterkamp, Gerard ^a   Daemen, Mat ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CHOLESTEROL; GLYCOPHORIN A; INTERLEUKIN 6; INTERLEUKIN 8;

ACUTE CORONARY SYNDROME; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; DIAGNOSTIC VALUE; EDITORIAL; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; MACROPHAGE FUNCTION; MONOCYTE; PRIORITY JOURNAL;

ATHEROSCLEROSIS; BIOLOGICAL MARKERS; ERYTHROCYTE MEMBRANE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-8;

EID: 56449112484     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehn469     Document Type: Editorial

References (9)

1. Liuzzo G, Angiolillo DJ, Buffon A, Rizzello V, Colizzi C, Ginnetti F, Biasucci LM, Maseri A. Enhanced response of blood monocytes to in vitro lipopolysaccharide-challenge in patients with recurrent unstable angina. Circulation 2001;103:2236-2241.
2. Batista ML Jr, Santos RV, Oliveira EM, Seelaender MC, Costa Rosa LF. Endurance training restores peritoneal macrophage function in post-MI congestive heart failure rats. J Appl Physiol 2007;102:2033-2039.
3. Versteeg D, Hoefer IE, Schoneveld AH, de Kleijn DP, Busser E, Strijder C, Emons M, Stella PR, Doevendans PA, Pasterkamp G. Monocyte toll-like receptor 2 and 4 responses and expression following percutaneous coronary intervention: association with lesion stenosis and fractional flow reserve. Heart 2008;94:770-776.
4. Arbustini E, Morbini P, D'Armini AM, Repetto A, Minzioni G, Piovella F, Viganó M, Tavazzi L. Plaque composition in plexogenic and thromboembolic pulmonary hypertension: the critical role of thrombotic material in pultaceous core formation. Heart 2002;88:177-182.
5. Kolodgie FD, Gold HK, Burke AP, Fowler DR, Kruth HS, Weber DK, Farb A, Guerrero LJ, Hayase M, Kutys R, Narula J, Finn AV, Virmani R. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 2003;349:2316-2325.
6. Tziakas DN, Kaski JC, Chalikias GK, Romero C, Fredericks S, Tentes IK, Kortsaris AX, Hatseras DI, Holt DW. Total cholesterol content of erythrocyte membranes is increased in patients with acute coronary syndrome: a new marker of clinical instability? J Am Coll Cardiol 2007;49:2081-2089.
7. Block RC, Harris WS, Reid KJ, Sands SA, Spertus JA. EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls. Atherosclerosis 2008;197:821-828.
8. Tziakas DN, Chalikias GK, Tentes IK, Stakos D, Chatzikyriakou SV, Mitrousi K, Kortsaris AX, Kaski JC, Boudoulas H. Interleukin-8 is increased in the membrane of circulating erythrocytes in patients with acute coronary syndrome. Eur Heart J 2008;29:2713-2722. First published on September 2, 2008. doi:10.1093/eurheartj/ehn382.
9. de Winter RJ, Manten A, de Jong YP, Adams R, van Deventer SJ, Lie KI. Interleukin 8 released after acute myocardial infarction is mainly bound to erythrocytes. Heart 1997;78:598-602.